Quantcast
Last updated on May 23, 2013 at 19:58 EDT

Latest Upsher-Smith Laboratories Inc. Stories

2010-02-22 06:30:00

MAPLE GROVE, Minn., Feb. 22 /PRNewswire/ -- More people around the world die annually from heart disease than from any other cause.(1) One of the major factors contributing to heart disease is cholesterol.(2) Two options for cholesterol management include statins, such as Lipitor® or Zocor®, and niacin dietary supplements, such as Slo-Niacin®. Statins decrease low-density lipoprotein (LDL) "bad" cholesterol. Niacin, in the form of nicotinic acid, not only lowers LDL and...

2010-02-10 06:30:00

MAPLE GROVE, Minn., Feb. 10 /PRNewswire/ --Cardiovascular disease (commonly referred to as heart disease) is the leading cause of death for women worldwide. (1) Almost every minute, a woman in the U.S. dies from heart disease. Despite the prevalence of heart disease in women, a 2005 American Heart Association study showed that 92% of primary care physicians and 83% of cardiologists were not aware of the fact that more women than men die of heart disease each year. (1) "Major initiatives are...

2010-02-02 08:00:00

MAPLE GROVE, Minn., Feb. 2 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. is pleased to announce the introduction of a new formulation of PreNexa® Rx prenatal vitamins. The new formulation contains an increased amount of algal-oil, plant-based docosahexaenoic acid (DHA), from 265 mg to 300 mg and increased vitamin D3, from 170 IU to 400 IU.(1) DHA, a key omega-3 fatty acid used throughout the body, helps support fetal and infant brain and eye development.(2,3) Vitamin D is an essential...

2009-12-03 08:19:00

MAPLE GROVE, Minn., Dec. 3 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the next phase of its strategic plan for central nervous system (CNS) diseases with USL255 (extended release topiramate), an internally developed program for the management of epilepsy. USL255 is being developed with Upsher-Smith's proprietary formulation technology and will enter a phase III clinical trial in early 2010 for the adjunctive treatment of epilepsy patients with partial onset seizures....

2009-11-16 11:36:00

MAPLE GROVE, Minn., Nov. 16 /PRNewswire/ -- Results of the SLIM Study ("Slo-Niacin® and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia") were recently published in the Journal of Clinical Lipidology. The objective was to study the lipid and anti-inflammatory effects of Slo-Niacin® 1.5 g/day and Lipitor (atorvastatin calcium) 10 mg/day, given alone and then together in persons with features of combined hyperlipidemia, high triglycerides, low...

2009-10-29 07:00:00

MAPLE GROVE, Minn., Oct. 29 /PRNewswire/ -- As American Diabetes Month approaches, leading experts like Dr. Jacqueline Sutera, DPM, stress the importance of foot care, especially for those with diabetes. People with diabetes are at a greater risk of developing dry skin due to nerve damage.(1,2) In the United States 23.6 million people have diabetes.(3) While the disease may present many challenges, most skin conditions associated with diabetes can be prevented, or if detected early, easily...

2009-08-27 07:00:00

MAPLE GROVE, Minn., Aug. 27 /PRNewswire/ -- Today Upsher-Smith Laboratories, Inc. launched a new website for its transdermal, bioidentical and FDA-approved hormone therapy product Divigel(R) (estradiol gel) 0.1%, www.divigel.com. The website offers a comprehensive resource of information to women who are seeking to educate themselves about menopause, its common symptoms of hot flashes and associated night sweats, and more importantly how to gain relief. "www.divigel.com offers key facts...

2009-08-10 08:00:00

MINNEAPOLIS, Aug. 10 /PRNewswire/ -- A leading expert, Dr. Alan Fleischer, professor and chair of the department of dermatology at Wake Forest University School of Medicine, recommends using a moisturizer with lactic acid, like AmLactin(R), to manage the dry skin associated with Keratosis Pilaris (KP). Lactic acid is an effective humectant, or substance that attracts water molecules to the skin to keep it hydrated. Approximately 40 percent of the world's population has Keratosis Pilaris...

2009-07-09 10:37:00

MINNEAPOLIS, July 9 /PRNewswire/ -- "Keratosis Pilaris," "Keratosis Pilaris." Hmm, sounds weird, doesn't it? Besides sounding weird, it's a common skin condition that according to the American Academy of Dermatology nags 40 percent of the world's population(1), yet there is no cure. The AmLactin(R) family of moisturizers is launching www.littleredbumps.com, a website devoted to the management of the dry skin associated with Keratosis Pilaris also known as KP. To view the Multimedia News...

2009-06-30 07:00:00

Data shows a very high percentage of women responded favorably to a bioidentical and FDA approved hormone therapy for hot flashes MAPLE GROVE, Minn., June 30 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. presented the results of a secondary analysis to determine the response rates to three doses of transdermal Divigel(R) (estradiol gel) 0.1 percent at the recent 57th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG) in Chicago. The objectives of...